News Room

Shortages and volatility of pricing for SMS have required us to make temporary changes in the materials used in the production of sterile fields for some of our Skin Lesion, Catheter and IV Starter Packs, in order to ensure continuity of supply of these important products.

Brad Albury, Head of Sales at Multigate, shares some of the challenges experienced during the global pandemic and highlights actions Multigate has recently taken to ensure the continuity of supply of essential medical products for our customers.

Pre-Easter COVID-19 market update. Ben Chen, Multigate CEO, provides an update on Multigate’s efforts to support Australia’s response to the COVID-19 pandemic.

On 3 February 2020, Multigate advised the marketplace that we would restrict supply to our existing customers only and limit orders to pre-Coronavirus forecasted demand quantities. Due to current conditions, these restrictions will continue to remain in effect for now.

Multigate will transition to a new phone system on Wednesday the 26th of February. We are not expecting any significant disruption to our ability to take your calls during this change-over. However, as part of our risk planning, we have put in place the following back-up measure.